|
Volumn 23, Issue 8, 2009, Pages 593-602
|
Second-generation de novo design: A view from a medicinal chemist perspective
|
Author keywords
Feature Trees; FlexNovo; Fragment space; FragView; NovoBench; Structure based de novo design; SYLVIA; Synthetic accessibility; Validation study
|
Indexed keywords
COMPLEXATION;
SEARCH ENGINES;
DE NOVO DESIGN;
FEATURE TREE;
FLEXNOVO;
FRAGMENT SPACE;
FRAGVIEW;
NOVOBENCH;
STRUCTURE-BASED;
STRUCTURE-BASED DE NOVO DESIGN;
SYLVIA;
SYNTHETIC ACCESSIBILITY;
VALIDATION STUDY;
LIGANDS;
4 (1,2 DIPHENYL 1 BUTENYL)CINNAMIC ACID;
BETA SECRETASE;
BETA SECRETASE INHIBITOR;
CHECKPOINT KINASE 1;
ESTROGEN RECEPTOR;
PEPTIDOMIMETIC AGENT;
PHOSPHODIESTERASE;
PROTEIN KINASE;
PROTEIN KINASE INHIBITOR;
ARTICLE;
BINDING AFFINITY;
BINDING SITE;
COMPUTER AIDED DESIGN;
COMPUTER PROGRAM;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG SCREENING;
DRUG STRUCTURE;
HYDROGEN BOND;
LIGAND BINDING;
MATHEMATICAL COMPUTING;
MOLECULAR DOCKING;
PHYSICAL CHEMISTRY;
PRIORITY JOURNAL;
PROTEIN BINDING;
ALGORITHMS;
COMPUTER-AIDED DESIGN;
DRUG DESIGN;
HUMANS;
LIGANDS;
MOLECULAR CONFORMATION;
PROTEIN BINDING;
PROTEINS;
SMALL MOLECULE LIBRARIES;
SOFTWARE;
|
EID: 67650945012
PISSN: 0920654X
EISSN: 15734951
Source Type: Journal
DOI: 10.1007/s10822-009-9291-2 Document Type: Article |
Times cited : (33)
|
References (23)
|